People's United Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-34
| Closed | -$3K | – | 756 |
|
|
2019
Q1 | $3K | Buy |
+34
| New | +$3K | ﹤0.01% | 709 |
|
|
2018
Q3 | – | Sell |
-2,130
| Closed | -$210K | – | 747 |
|
|
2018
Q2 | $210K | Hold |
2,130
| – | – | 0.01% | 753 |
|
|
2018
Q1 | $254K | Hold |
2,130
| – | – | 0.01% | 644 |
|
|
2017
Q4 | $271K | Buy |
+2,130
| New | +$271K | 0.01% | 637 |
|
|
2016
Q1 | – | Sell |
-2,130
| Closed | -$201K | – | 862 |
|
|
2015
Q4 | $201K | Buy |
+2,130
| New | +$201K | 0.01% | 445 |
|
|
2015
Q3 | – | Sell |
-2,140
| Closed | -$256K | – | 872 |
|
|
2015
Q2 | $256K | Buy |
2,140
+10
| +0.5% | +$1.2K | 0.01% | 415 |
|
|
2015
Q1 | $222K | Hold |
2,130
| – | – | 0.01% | 426 |
|
|
2014
Q4 | $207K | Buy |
+2,130
| New | +$207K | 0.01% | 437 |
|